<?xml version="1.0" encoding="UTF-8"?>
<p id="p0330">A yeast cell-based method was established based on the finding that coronavirus methyltransferase can functionally replace a methyltransferase essential for yeast viability (
 <xref rid="bb0280" ref-type="bibr">Chen et al., 2009</xref>, 
 <xref rid="bb1640" ref-type="bibr">Sun et al., 2014</xref>). In this method, Sun 
 <italic>et al</italic>. constructed recombinant yeasts producing the viral methyltransferase instead of the yeast one (
 <xref rid="bb1640" ref-type="bibr">Sun et al., 2014</xref>). This strain was used for a HTS of methyltransferase inhibitor activity that negatively correlated with the cell density after 20Â h incubation.
</p>
